Skip to main content
AAN.com
Article
January 11, 2019

The neuronal network of laughing in young patients with untreated narcolepsy

January 29, 2019 issue
92 (5) e504-e515

Abstract

Objective

To investigate the neuronal correlates of spontaneous laughter in drug-naive pediatric patients with narcolepsy type I (NT1) compared to healthy controls by means of blood oxygen level-dependent (BOLD) MRI.

Methods

Twenty-one children/adolescents with recent onset of NT1 and 21 age- and sex-matched healthy controls were studied with fMRI while viewing funny videos using a naturalistic paradigm. Whole-brain hemodynamic correlates of spontaneous laughter were investigated in each group and compared by use of appropriate second-level general linear model analyses. If recorded, cataplexy events were treated as the effect of no interest at the single-participant level. Correlations analyses between these contrasts and behavioral findings were performed.

Results

Emotion-induced laughter occurred in 16 patients (294 events) and 21 controls (357 events). In controls, laughter-related BOLD increases involved a widespread cortical and subcortical network including the bilateral motor and premotor areas, cingulated cortex, insula, and amygdala. In NT1, laughter induced BOLD signal increments in the motor cortex, right thalamus, and left subthalamic nucleus/zona incerta (STN/ZI). STN/ZI and thalamic changes were significantly higher during fMRI sessions with laughter without cataplexy compared to sessions in which laughter was associated with cataplexy.

Conclusion

Laughter expression in individuals with NT1 involves different brain circuits compared to controls by means of overactivation of cortical and subcortical regions belonging to the volitional control of laughter. The activation of the STN/ZI region observed predominantly in patients with NT1 during laugh episodes without cataplexy suggests that the ZI could act to prevent cataplexy.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.
2.
Dauvillers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH. Cataplexy: clinical aspects, pathophysiology and management strategy. Nat Rev Neurol 2014;10:386–395.
3.
Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991–997.
4.
Meletti S, Vaudano AE, Pizza F, et al. The brain correlates of laugh and cataplexy in childhood narcolepsy. J Neurosci 2015;35:11583–11594.
5.
Kovacs M. The Children's Depression Inventory (CDI). Psychopharmacol Bull 1985;21:995–998.
6.
Postiglione E, Antelmi E, Pizza F, et al. The clinical spectrum of childhood narcolepsy. Sleep Med Rev 2018;38:70–85.
7.
Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97–113.
8.
Pizza F, Franceschini C, Peltola H, et al. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain 2013;136:3787–3795.
9.
Vandi S, Pizza F, Antelmi E, et al. A standardized test to document cataplexy. Sleep Med Epub 2017 Oct 9.
10.
Watson PF, Petrie A. Method agreement analysis: a review of correct methodology. Theriogenology 2010;73:1167–1179.
11.
Ruggieri A, Vaudano AE, Benuzzi F, et al. Mapping (and modeling) physiological movements during EEG-fMRI recordings: the added value of the VIDEO acquired simultaneously. J Neurosci Methods 2015;239:223–237.
12.
Plazzi G, Pizza F, Palaia V, et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011;134:3480–3492.
13.
Moran JM, Wig GS, Adams RB Jr, Janata P, Kelley WM. Neural correlates of humor detection and appreciation. Neuroimage 2004;21:1055–1060.
14.
Friston KJ, Williams S, Howard R, Frackowiak RS, Turner R. Movement-related effects in fMRI time-series. Magn Reson Med 1996;35:346–355.
15.
Lemieux L, Laufs H, Carmichael D, Paul JS, Walker MC, Duncan JS. Non-canonical spike-related BOLD responses in focal epilepsy. Hum Brain Mapp 2008;29:329–345.
16.
Friston KJ, Stephan KE, Lund TE, Morcom A, Kiebel S. Mixed-effects and fMRI studies. Neuroimage 2005;24:244–252.
17.
Beckmann CF, Jenkinson M, Smith SM. General multilevel linear modeling for group analysis in FMRI. Neuroimage 2003;20:1052–1063.
18.
Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 1996;4:58–73.
19.
Poldrack RA. Region of interest analysis for fMRI. Soc Cogn Affect Neurosci 2007;2:67–70.
20.
Morel A, Magnin M, Jeanmonod D. Multiarchitectonic and stereotactic atlas of the human thalamus. J Comp Neurol 1997;387:588–630.
21.
Krauth A, Blanc R, Poveda A, Jeanmonod D, Morel A, Székely G. A mean three-dimensional atlas of the human thalamus: generation from multiple histological data. Neuroimage 2010;49:2053–2062.
22.
Fleming SM, Thomas CL, Dolan RJ. Overcoming status quo bias in the human brain. Proc Natl Acad Sci USA 2010;107:6005–6009.
23.
Van Essen DC. A population-average, landmark- and surface-based (PALS) atlas of human cerebral cortex. NeuroImage 2005;28:635–662.
24.
Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB. Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 2008;22:531–545.
25.
Faul F, Erdfelder E, Lang AG, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175–191.
26.
Overeem S, van Nues SJ, van der Zande WL, Donjacour CE, van Mierlo P, Lammers GJ. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med 2011;12:12–18.
27.
Matos N, Gaig C, Santamaria J, Iranzo A. Tricks to rapidly terminate episodes of cataplexy in narcolepsy. Sleep Med 2016;20:129–130.
28.
Reiss AL, Hoeft F, Tenforde AS, Chen W, Mobbs D, Mignot EJ. Anomalous hypothamamic responses to humor in cataplexy. PLoS One 2008;3:e2225.
29.
Susta M, Nemcova V, Bizik G, Sonka K. Emotion stimulus processing in narcolepsy with cataplexy. J Sleep Res 2017;26:30–37.
30.
Caruana F, Gozzo F, Pelliccia V, Cossu M, Avanzini P. Smile and laughter elicited by electrical stimulation of the frontal operculum. Neuropsychologia 2016;89:364–370.
31.
Kerl HU, Gerigk L, Brockmann MA, et al. Imaging for deep brain stimulation: the zona incerta at 7 Tesla. World J Radiol 2013;5:5–16.
32.
Plaha P, Ben-Shlomo Y, Patel NK, Gill SS. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 2006;129:1732–1747.
33.
Sandvik U, Hariz GM, Blomstedt P. Quality of life following DBS in the caudal zona incerta in patients with essential tremor. Acta Neurochir (Wien) 2012;154:495–499.
34.
Ferreira JGP, Bittencourt JC, Adamantidis A. Melanin-concentrating hormone and sleep. Curr Opin Neurobiol 2017;44:152–158.
35.
Pelluru D, Konadhode RR, Shiromani PJ. MCH neurons are the primary sleep-promoting group. Sleep 2013;36:1779–1781.
36.
Verret L, Goutagny R, Fort P, et al. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci 2003;4:19.
37.
Liu M, Blanco-Centurion C, Konadhode R, et al. Orexin gene transfer into zona incerta neurons suppresses muscle paralysis in narcoleptic mice. J Neurosci 2011;31:6028–6040.
38.
Mitrofanis J. Some certainty for the “zone of uncertainty”? Exploring the function of the zona incerta. Neuroscience 2005;130:1–15.
39.
Siegel JM. Hypocretin (orexin): role in normal behavior and neuropathology. Annu Rev Psychol 2004;55:125–148.
40.
Lambert C, Simon H, Colman J, Barrick TR. Defining thalamic nuclei and topographic connectivity gradients in vivo. Neuroimage 2017;158:466–479.
41.
Allen AE, Procyk CA, Brown TM, Lucas RJ. Convergence of visual and whisker responses in the primary somatosensory thalamus (ventral posterior medial region) of the mouse. J Physiol 2017;595:865–881.
42.
de Bourbon-Teles J, Bentley P, Koshino S, et al. Thalamic control of human attention driven by memory and learning. Curr Biol 2014;24:993–999.
43.
Beck AK, Lütjens G, Schwabe K, Dengler R, Krauss JK, Sandmann P. Thalamic and basal ganglia regions are involved in attentional processing of behaviorally significant events: evidence from simultaneous depth and scalp EEG. Brain Struct Funct 2018;223:461–474.
44.
de Hollander G, Keuken MC, Forstmann BU. The subcortical cocktail problem; mixed signals from the subthalamic nucleus and substantia nigra. PLoS One 2015;10:e0120572.
45.
Mikl M, Marecek R, Hlustík P, et al. Effects of spatial smoothing on fMRI group inferences. Magn Reson Imaging 2008;26:490–503.
46.
Geissler A, Lanzenberger R, Barth M, et al. Influence of fMRI smoothing procedures on replicability of fine scale motor localization. Neuroimage 2005;24:323–331.
47.
Mobbs D, Greicius MD, Abdel-Azim E, Menon V, Reiss AL. Humor modulates the mesolimbic reward centers. Neuron 2003;40:1041–1048.
48.
Neely MN, Walter E, Black JM, Reiss AL. Neural correlates of humor detection and appreciation in children. J Neurosci 2012;32:1784–1790.
49.
Gibson WS, Cho S, Abulseoud OA, et al. The impact of mirth-inducing ventral striatal deep brain stimulation on functional and effective connectivity. Cereb Cortex 2017;27:2183–2194.

Information & Authors

Information

Published In

Neurology®
Volume 92Number 5January 29, 2019
Pages: e504-e515

Publication History

Received: April 25, 2018
Accepted: September 28, 2018
Published online: January 11, 2019
Published in issue: January 29, 2019

Permissions

Request permissions for this article.

Disclosure

A. Vaudano reports no disclosures relevant to the manuscript. F. Pizza has received personal compensation as a scientific advisory board member for UCB and Bioproject. F. Talami reports no disclosures relevant to the manuscript. G. Plazzi received research grant support from Fondazione Banca del Monte di Bologna and Bioproject, and personal compensation as a scientific advisory board member for UCB pharma (Europe), Jazz Pharmaceuticals, and Bioproject. S. Meletti received research grant support from the Ministry of Health and the nonprofit organization Foundation “Fondazione Cassa di Risparmio di Modena–FCRM” and has received personal compensation as a scientific advisory board member for UCB and EISAI. Go to Neurology.org/N for full disclosures.

Study Funding

No targeted funding reported.

Authors

Affiliations & Disclosures

Anna Elisabetta Vaudano, MD, PhD https://orcid.org/0000-0002-6280-7526
From the Department of Medicine and Surgery (A.E.V.), Sleep Medicine Center, University of Parma; Department of Biomedical, Metabolic, and Neural Science (A.E.V., S.M.) and Center for Neuroscience and Neurotechnology (A.E.V., S.M.), University of Modena and Reggio Emilia; Department of Biomedical and Neuromotor Sciences (F.P., G.P.), University of Bologna; IRCCS Istituto Delle Scienze Neurologiche di Bologna (F.P., G.P.); and Neurology Unit (F.T., S.M.), OCSAE Azienda Ospedaliero-Universitaria, Modena, Italy.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
(1) Ministry of Health (MOH), Emilia-Romagna Region, GRANT Number: PRUA1GR-2013-00000120, Principal Investigator, 2015-2016.
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Fabio Pizza, MD, PhD
From the Department of Medicine and Surgery (A.E.V.), Sleep Medicine Center, University of Parma; Department of Biomedical, Metabolic, and Neural Science (A.E.V., S.M.) and Center for Neuroscience and Neurotechnology (A.E.V., S.M.), University of Modena and Reggio Emilia; Department of Biomedical and Neuromotor Sciences (F.P., G.P.), University of Bologna; IRCCS Istituto Delle Scienze Neurologiche di Bologna (F.P., G.P.); and Neurology Unit (F.T., S.M.), OCSAE Azienda Ospedaliero-Universitaria, Modena, Italy.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Fee for speaking at a symposium (UCB Pharma)
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Francesca Talami, PsyD
From the Department of Medicine and Surgery (A.E.V.), Sleep Medicine Center, University of Parma; Department of Biomedical, Metabolic, and Neural Science (A.E.V., S.M.) and Center for Neuroscience and Neurotechnology (A.E.V., S.M.), University of Modena and Reggio Emilia; Department of Biomedical and Neuromotor Sciences (F.P., G.P.), University of Bologna; IRCCS Istituto Delle Scienze Neurologiche di Bologna (F.P., G.P.); and Neurology Unit (F.T., S.M.), OCSAE Azienda Ospedaliero-Universitaria, Modena, Italy.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
(1) Clinique La Prairie
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Giuseppe Plazzi, MD, PhD
From the Department of Medicine and Surgery (A.E.V.), Sleep Medicine Center, University of Parma; Department of Biomedical, Metabolic, and Neural Science (A.E.V., S.M.) and Center for Neuroscience and Neurotechnology (A.E.V., S.M.), University of Modena and Reggio Emilia; Department of Biomedical and Neuromotor Sciences (F.P., G.P.), University of Bologna; IRCCS Istituto Delle Scienze Neurologiche di Bologna (F.P., G.P.); and Neurology Unit (F.T., S.M.), OCSAE Azienda Ospedaliero-Universitaria, Modena, Italy.
Disclosure
Scientific Advisory Boards:
1.
Serving on a scientific advisory board for UCB Pharma, JAZZ pharmaceuticals and Bioprojet
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Editorial board member of Sleep Medicine and Sleep Medicine Reviews
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Stefano Meletti, MD, PhD
From the Department of Medicine and Surgery (A.E.V.), Sleep Medicine Center, University of Parma; Department of Biomedical, Metabolic, and Neural Science (A.E.V., S.M.) and Center for Neuroscience and Neurotechnology (A.E.V., S.M.), University of Modena and Reggio Emilia; Department of Biomedical and Neuromotor Sciences (F.P., G.P.), University of Bologna; IRCCS Istituto Delle Scienze Neurologiche di Bologna (F.P., G.P.); and Neurology Unit (F.T., S.M.), OCSAE Azienda Ospedaliero-Universitaria, Modena, Italy.
Disclosure
Scientific Advisory Boards:
1.
S. Meletti has served on scientific advisory boards for UCB and EISAI.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Editorial board Member of: - Epileptic Disorder - PlosOne
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
S.Meletti provided consultancies for UCB and EISAI
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
MOH, grant number RF-2011-02350485; co-investigator; 2011- 2014. MOH, grant number RF-2013-02355313; co-PI
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
CaRisMo Foundation, 2010-2013;
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Vaudano [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

Author Contributions

A.E. Vaudano: MRI data acquisition, design and conceptualization of the study, analysis and interpretation of data, statistical analysis, drafting and revising the manuscript. F. Talami: MRI data acquisition, analysis and interpretation of data. F. Pizza and G. Plazzi. clinical data acquisition, design and conceptualization of the study, analysis and interpretation of data, drafting and revising the manuscript. S. Meletti: design and conceptualization of the study, analysis and interpretation of data, drafting and revising the manuscript.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Neural processing of laughter in depression, Scientific Reports, 15, 1, (2025).https://doi.org/10.1038/s41598-025-97385-6
    Crossref
  2. Narcolepsy and rapid eye movement sleep, Journal of Sleep Research, 34, 2, (2024).https://doi.org/10.1111/jsr.14277
    Crossref
  3. Theory of Mind impairment in childhood narcolepsy type 1: a case–control study, Brain Communications, 6, 2, (2024).https://doi.org/10.1093/braincomms/fcae063
    Crossref
  4. Phenomenology and psychiatric correlates of pseudocataplexy, SLEEP, 47, 11, (2023).https://doi.org/10.1093/sleep/zsad234
    Crossref
  5. Amygdala neurocircuitry at the interface between emotional regulation and narcolepsy with cataplexy, Frontiers in Neuroscience, 17, (2023).https://doi.org/10.3389/fnins.2023.1152594
    Crossref
  6. Narcolepsy and emotions: Is there a place for a theory of mind approach?, Sleep Medicine, 102, (84-89), (2023).https://doi.org/10.1016/j.sleep.2022.12.013
    Crossref
  7. When laughter arrests speech: fMRI-based evidence, Philosophical Transactions of the Royal Society B: Biological Sciences, 377, 1863, (2022).https://doi.org/10.1098/rstb.2021.0182
    Crossref
  8. Narcolepsy, Journal of Sleep Research, 31, 4, (2022).https://doi.org/10.1111/jsr.13631
    Crossref
  9. Dream Activity in Narcoleptic Patients During the COVID-19 Lockdown in Italy, Frontiers in Psychology, 12, (2021).https://doi.org/10.3389/fpsyg.2021.681569
    Crossref
  10. Abnormal Brain Network Topology During Non–rapid Eye Movement Sleep and Its Correlation With Cognitive Behavioral Abnormalities in Narcolepsy Type 1, Frontiers in Neurology, 11, (2021).https://doi.org/10.3389/fneur.2020.617827
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Short Form

Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share